TCM
KERX

Tamarack Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Tamarack Capital Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-950,000
Closed -$12.1M – 44
2015
Q1 		$12.1M Buy
+950,000
New +$12.2M 1.59% 22

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Tamarack Capital Management's KERX Position: Q2 2015 in Review

Tamarack Capital Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q2 2015, closing a stake of 950,000 shares — an estimated $12.1M sold.

Tamarack Capital Management first reported a position in KERX in Q1 2015 and held it in 1 quarter. The position peaked at $12.1M in Q1 2015. 153 funds tracked by Wall St. Rank hold KERX as of Q2 2015.

  • Tamarack Capital Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
  • Tamarack Capital Management sold 950,000 Keryx Biopharmaceuticals Inc shares in Q2 2015, an estimated $12.1M.
  • Tamarack Capital Management first reported a position in Keryx Biopharmaceuticals Inc in Q1 2015 and held it in 1 quarter.
  • Tamarack Capital Management's Keryx Biopharmaceuticals Inc position peaked at $12.1M in Q1 2015.
  • 153 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q2 2015.

Based on Tamarack Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.